Pancreatic Cancer Research

ResearcherInsermNo recent work listed

Christophe Cassinotto

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5136-4742; OpenAlex author ID A5025235110. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
24
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper · 2017: 3 papers · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 8

  1. Imaging of Pancreatic Ductal Adenocarcinoma: An Update on Recent Advances. Co-author DOI 10.1177/08465371221124927↗
  2. FOLFIRINOX-based neoadjuvant chemoradiotherapy for borderline and locally advanced pancreatic cancer: A pilot study from a tertiary centre. Co-author DOI 10.1016/j.dld.2019.03.004↗
  3. Pancreatic Adenocarcinoma Staging in the Era of Preoperative Chemotherapy and Radiation Therapy. Last author DOI 10.1148/radiol.2018171670↗
  4. CT evaluation after neoadjuvant FOLFIRINOX chemotherapy for borderline and locally advanced pancreatic adenocarcinoma. Co-author DOI 10.1007/s00330-016-4632-8↗
  5. Resectable pancreatic adenocarcinoma: Role of CT quantitative imaging biomarkers for predicting pathology and patient outcomes. Co-author DOI 10.1016/j.ejrad.2017.02.033↗
  6. Pancreatic adenocarcinoma: A simple CT score for predicting margin-positive resection in patients with resectable disease. Co-author DOI 10.1016/j.ejrad.2017.06.028↗
  7. Radiological evaluation of response to neoadjuvant treatment in pancreatic cancer. Co-author DOI 10.1016/j.diii.2016.07.011↗
  8. Locally advanced pancreatic adenocarcinoma: reassessment of response with CT after neoadjuvant chemotherapy and radiation therapy. Co-author DOI 10.1148/radiol.14132914↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. António Sá Cunha · 4 shared papers, 2014–2017 · strength 0.28
  2. L. Chiche · 4 shared papers, 2014–2019 · strength 0.26
  3. Christophe Laurent · 3 shared papers, 2014–2019 · strength 0.19
  4. Anna Pellat · 1 shared paper, 2023 · strength 0.18
  5. Maxime Barat · 1 shared paper, 2023 · strength 0.18
  6. Philippe A. Soyer · 1 shared paper, 2023 · strength 0.18
  7. Ugo Marchèse · 1 shared paper, 2023 · strength 0.18
  8. Elliot K. Fishman · 1 shared paper, 2023 · strength 0.18
  9. Romain Coriat · 1 shared paper, 2023 · strength 0.18
  10. Linda Chi Hang Chu · 1 shared paper, 2023 · strength 0.18
  11. B. Gallix · 2 shared papers, 2017 · strength 0.14
  12. George Zogopoulos · 2 shared papers, 2017 · strength 0.14
  13. Marc Zins · 1 shared paper, 2018 · strength 0.14
  14. Celso Matos · 1 shared paper, 2018 · strength 0.14
  15. Hervé Trillaud · 2 shared papers, 2014–2016 · strength 0.13
  16. Jean‐Frédéric Blanc · 2 shared papers, 2014–2019 · strength 0.12
  17. V. Vendrely · 2 shared papers, 2014–2019 · strength 0.12
  18. Claudia Pouypoudat · 1 shared paper, 2019 · strength 0.08
  19. Étienne Buscail · 1 shared paper, 2019 · strength 0.08
  20. Sandrine Dabernat · 1 shared paper, 2019 · strength 0.08
  21. Daniel Pietrasz · 1 shared paper, 2017 · strength 0.07
  22. Mathilde Wagner · 1 shared paper, 2017 · strength 0.07
  23. Jean‐Baptiste Bachet · 1 shared paper, 2017 · strength 0.07
  24. Michel Montaudon · 1 shared paper, 2014 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.